Subdural haemorrhage is associated with recent morphine treatment in patients with cancer: A retrospective population-based nested case-control study

References

• Ducruet AF, Grobelny BT, Zacharia BE, Hickman ZL, DeRosa PL, Anderson K, Sussman E, Carpenter A, Connolly ES Jr. The surgical management of chronic subdural hematoma. Neurosurgical Review 2012;35:155–169; discussion 169
   PubMed Web of Science ®Google Scholar
• Rogers LR. Cerebrovascular complications in patients with cancer. Seminars in Neurology 2010;30:311–319
   PubMed Web of Science ®Google Scholar
• Gordon DB, Dahl JL, Miaskowski C, McCarberg B, Todd KH, Paice JA, Lipman AG, Bookbinder M, Sanders SH, Turk DC, Carr DB. American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Archives of Internal Medicine 2005;165:1574–1580
   PubMed Web of Science ®Google Scholar
• Quigley C. Opioids in people with cancer-related pain. Clinical Evidence 2008;07:2408
   Google Scholar
• Koyyalagunta D, Bruera E, Solanki DR, Nouri KH, Burton AW, Toro MP, Bruel BM, Manchikanti L. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician 2012;15(Suppl 3):ES39–58
   PubMedGoogle Scholar
• Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database System Review 2007;(4):CD003868
   Google Scholar
• Flemming K. The use of morphine to treat cancer-related pain: A synthesis of quantitative and qualitative research. Journal of Pain and Symptom Management 2010;39:139–154
   PubMedGoogle Scholar
• Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. Journal of Internal Medicine 2006;260:76–87
   PubMed Web of Science ®Google Scholar
• Hass B, Lungershausen J, Hertel N, Poulsen Nautrup B, Kotowa W, Liedgens H. Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: A model approach. The European Journal of Health Economics: Health Economics in Prevention and Care 2009;10:309–321
   PubMed Web of Science ®Google Scholar
• Borne J, Riascos R, Cuellar H, Vargas D, Rojas R. Neuroimaging in drug and substance abuse part II: Opioids and solvents. Topics in Magnetic Resonance Imaging 2005;16:239–245
   PubMedGoogle Scholar
• Caplan LR, Hier DB, Banks G. Current concepts of cerebrovascular disease–stroke: Stroke and drug abuse. Stroke 1982;13:869–872
   PubMed Web of Science ®Google Scholar
• Sloan MA, Kittner SJ, Rigamonti D, Price TR. Occurrence of stroke associated with use/abuse of drugs. Neurology 1991;41:1358–1364
   PubMedGoogle Scholar
• Jensen R, Olsen TS, Winther BB. Severe non-occlusive ischemic stroke in young heroin addicts. Acta Neurologica Scandinavica 1990;81:354–357
   PubMed Web of Science ®Google Scholar
• Lee CW, Muo CH, Liang JA, Sung FC, Kao CH. Association of intensive morphine treatment and increased stroke incidence in prostate cancer patients: A population-based nested case-control study. Japanese Journal of Clinical Oncology 2013;43:776–781
   PubMedGoogle Scholar
• McKenzie CR, Rengachary SS, McGregor DH, Dixon AY, Suskind DL. Subdural hematoma associated with metastatic neoplasms. Neurosurgery 1990;27:619–624; discussion 24–25
   PubMed Web of Science ®Google Scholar
• Lieu AS, Hwang SL, Howng SL, Chai CY. Brain tumors with hemorrhage. Journal of the Formosan Medical Association 1999;98:365–367
   PubMed Web of Science ®Google Scholar
• Wakai S, Yamakawa K, Manaka S, Takakura K. Spontaneous intracranial hemorrhage caused by brain tumor: Its incidence and clinical significance. Neurosurgery 1982;10:437–444
   PubMed Web of Science ®Google Scholar
• Mandybur TI. Intracranial hemorrhage caused by metastatic tumors. Neurology 1977;27:650–655
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Opioids and the management of chronic severe pain in the elderly: Consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Practice: The Official Journal of World Institute of Pain 2008;8:287–313
   PubMedGoogle Scholar
• Higginson IJ, Davies E, Tsouros AD. The end of life: Unknown and unplanned? The European Journal of Public Health 2007;17:331–332
   PubMedGoogle Scholar
• Yang Q, Xie DR, Jiang ZM, Ma W, Zhang YD, Bi ZF, Chen DL. Efficacy and adverse effects of transdermal fentanyl and sustained-release oral morphine in treating moderate-severe cancer pain in Chinese population: A systematic review and meta-analysis. Journal of Experimental & Clinical Cancer Research 2010;29:67
   PubMedGoogle Scholar